308 related articles for article (PubMed ID: 25311468)
1. Use of laboratory tests to guide initiation of autologous hematopoietic progenitor cell collection by apheresis: results from the multicenter hematopoietic progenitor cell collection by Apheresis Laboratory Trigger Survey.
Makar RS; Padmanabhan A; Kim HC; Anderson C; Sugrue MW; Linenberger M
Transfus Med Rev; 2014 Oct; 28(4):198-204. PubMed ID: 25311468
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis.
Lefrère F; Zohar S; Beaudier S; Audat F; Ribeil JA; Ghez D; Varet B; Cavazzana-Calvo M; Dal Cortivo L; Letestu R; McIntyre E; Brouzes C
Transfusion; 2007 Oct; 47(10):1851-7. PubMed ID: 17880611
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the predictive value of the hematopoietic progenitor cell count using an automated hematology analyzer for CD34+ stem cell mobilization and apheresis product yield.
Furundarena JR; Uranga A; Alkorta A; González C; Javier Ferreiro J; Rey M; Aragón L; Urreta I; Emparanza JI; Redín H; Garrido A; Araiz M
Int J Lab Hematol; 2020 Apr; 42(2):170-179. PubMed ID: 31830371
[TBL] [Abstract][Full Text] [Related]
4. Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.
Sheppard D; Tay J; Palmer D; Xenocostas A; Doulaverakis C; Huebsch L; McDiarmid S; Tinmouth A; Mallick R; Martin L; Birch P; Hamelin L; Allan D; Bredeson C
Biol Blood Marrow Transplant; 2016 Apr; 22(4):763-767. PubMed ID: 26643030
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood CD34+ cell enumeration as a predictor of apheresis yield: an analysis of more than 1,000 collections.
Gambell P; Herbert K; Dickinson M; Stokes K; Bressel M; Wall D; Harrison S; Prince HM
Biol Blood Marrow Transplant; 2012 May; 18(5):763-72. PubMed ID: 22227589
[TBL] [Abstract][Full Text] [Related]
6. Monitoring blood for CD34+ cells to determine timing of Hematopoietic Progenitor Cells Apheresis.
Vaughn ML; Waller EK
Methods Mol Biol; 2012; 904():79-83. PubMed ID: 22890923
[TBL] [Abstract][Full Text] [Related]
7. Venous access for hematopoietic progenitor cell collection: An international survey by the ASFA HPC donor subcommittee.
O'Leary MF; Dunbar NM; Kim HC; Draper NL; Linenberger M; Schwartz J; Miller Y; Murtaugh A; West FB; Fernando LP; Park YA
J Clin Apher; 2016 Dec; 31(6):529-534. PubMed ID: 26762291
[TBL] [Abstract][Full Text] [Related]
8. Discordant CD34+ cell results in peripheral blood and hematopoietic progenitor cell-apheresis product: implications for clinical decisions and impact on patient treatment.
Liwski CJ; Padley DJ; Gustafson MP; Winters JL; Gastineau DA; Jacob EK
Transfusion; 2014 Mar; 54(3):541-4. PubMed ID: 23808629
[TBL] [Abstract][Full Text] [Related]
9. Correlation between peripheral blood automated hematopoietic progenitor cell counts and flow cytometric CD34
Kim SM; Kim HY; Kim SJ; Jang JH; Kim K; Kim WS; Jung CW; Cho D; Kang ES
J Clin Apher; 2021 Oct; 36(5):737-749. PubMed ID: 34283414
[TBL] [Abstract][Full Text] [Related]
10. Correlations between hematopoietic progenitor cell counts as measured by Sysmex and CD34+ cell harvest yields following mobilization with different regimens.
Vogel W; Kopp HG; Kanz L; Einsele H
J Cancer Res Clin Oncol; 2002 Jul; 128(7):380-4. PubMed ID: 12136252
[TBL] [Abstract][Full Text] [Related]
11. The use of plerixafor in hematopoietic progenitor cell collection in pediatric patients: a single center experience.
Pham HP; Patel N; Semedei-Pomales M; Bhatia M; Schwartz J
Cytotherapy; 2012 Apr; 14(4):467-72. PubMed ID: 22339604
[TBL] [Abstract][Full Text] [Related]
12. Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells.
Hicks ML; Lonial S; Langston A; Flowers C; Roback JD; Smith KJ; Mossavi Sai S; Teagarden D; Hamilton ES; Waller EK; Kaufman J
Transfusion; 2007 Apr; 47(4):629-35. PubMed ID: 17381621
[TBL] [Abstract][Full Text] [Related]
13. Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34+ cell yield in the apheresis collection.
Yu J; Leisenring W; Fritschle W; Heimfeld S; Shulman H; Bensinger WI; Holmberg LA; Rowley SD
Bone Marrow Transplant; 2000 Jun; 25(11):1157-64. PubMed ID: 10849528
[TBL] [Abstract][Full Text] [Related]
14. Preharvest hematopoietic progenitor cell counts predict CD34+ cell yields in granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell harvest in healthy donors.
Yang SH; Wang TF; Tsai HH; Lin TY; Wen SH; Chen SH
Transfusion; 2010 May; 50(5):1088-95. PubMed ID: 20051055
[TBL] [Abstract][Full Text] [Related]
15. Use of the haematopoietic progenitor cell parameter in optimizing timing of peripheral blood stem cell harvest.
Padmanabhan A; Reich-Slotky R; Jhang JS; Dael S; Crowder T; Colovai AI; Schwartz J
Vox Sang; 2009 Aug; 97(2):153-9. PubMed ID: 19392781
[TBL] [Abstract][Full Text] [Related]
16. Use of the haemopoietic progenitor cell count of the Sysmex SE-9500 to refine apheresis timing of peripheral blood stem cells.
Pollard Y; Watts MJ; Grant D; Chavda N; Linch DC; Machin SJ
Br J Haematol; 1999 Aug; 106(2):538-44. PubMed ID: 10460620
[TBL] [Abstract][Full Text] [Related]
17. Harvesting autologous stem cells from a patient with red blood cell abnormalities of β-thalassemia intermedia.
Sanford K; Roseff SD; Anderson J; Chung HM; McPherson RA
Transfusion; 2014 Jul; 54(7):1881-6. PubMed ID: 24527966
[TBL] [Abstract][Full Text] [Related]
18. Successful collection and engraftment of autologous peripheral blood progenitor cells in poorly mobilized patients receiving high-dose granulocyte colony-stimulating factor.
Cooper DL; Proytcheva M; Medoff E; Seropian SE; Snyder EL; Krause DS; Wu Y
J Clin Apher; 2012 Nov; 27(5):235-41. PubMed ID: 22566214
[TBL] [Abstract][Full Text] [Related]
19. Optia® continuous mononuclear collection (CMNC) system is a safe and efficient system for hematopoietic progenitor cells-apheresis (HPC-a) collection and yields a lower product hematocrit (HCT%) than the COBE® spectra system: A retrospective study.
Pandey S; Cottler-Fox M
J Clin Apher; 2018 Aug; 33(4):505-513. PubMed ID: 29603795
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of new automated hematopoietic progenitor cell analysis in the clinical management of peripheral blood stem cell collections.
Peerschke EI; Moung C; Pessin MS; Maslak P
Transfusion; 2015 Aug; 55(8):2001-9. PubMed ID: 25808236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
